Compare INDI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDI | XOMA |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 750.1M | 746.0M |
| IPO Year | 2021 | N/A |
| Metric | INDI | XOMA |
|---|---|---|
| Price | $4.13 | $43.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $6.25 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 6.3M | 132.0K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.95 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $217,394,000.00 | N/A |
| Revenue This Year | $25.54 | $24.59 |
| Revenue Next Year | $38.45 | N/A |
| P/E Ratio | ★ N/A | $29.64 |
| Revenue Growth | ★ 0.33 | N/A |
| 52 Week Low | $2.32 | $22.29 |
| 52 Week High | $6.05 | $44.00 |
| Indicator | INDI | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 49.39 | 77.18 |
| Support Level | $4.03 | $40.76 |
| Resistance Level | $4.77 | N/A |
| Average True Range (ATR) | 0.40 | 0.50 |
| MACD | 0.06 | 0.12 |
| Stochastic Oscillator | 51.36 | 91.05 |
Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.